Please login to the form below

Not currently logged in
Email:
Password:

Neopharm

This page shows the latest Neopharm news and features for those working in and with pharma, biotech and healthcare.

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

The Merck agreement comes four years after Fresenius hived off its biotech business to the owners of Israeli group Neopharm, saying it wanted to narrow down its focus to intravenous drugs,

Latest news

  • Fresenius sells biotech business Fresenius sells biotech business

    Fresenius sells biotech business. Germany company's biotechnology arm picked up by Neopharm owners. ... German healthcare group Fresenius has sold its biotech business for an undisclosed amount to the owners of Neopharm, Israel's second-largest pharma

  • Novartis gains licence for GW's Sativex

    Sativex is licensed to Otsuka Pharmaceutical in the US, to Almirall in Europe (excluding the UK), to Bayer HealthCare in the UK and Canada, and to Neopharm Group in Israel/Palestine.

  • Going for gold

    Additionally, NeoPharm's liposomal candidate, LEP-ETU, is expected to enter phase II clinical trials for breast cancer in 2008.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics